Lipoid pneumonia secondary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 2: Line 2:


{{lipoid pneumonia}}
{{lipoid pneumonia}}
{{CMG}}; {{AE}}  
{{CMG}}; {{AE}} {{RG}}


==Overview==
==Overview==
There are no established measures for the secondary prevention of [disease name].
There are no established measures for the secondary prevention of lipoid pneumonia.
 
OR
 
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].


==Secondary Prevention==
==Secondary Prevention==
There are no established measures for the secondary prevention of [disease name].
There are no established measures for the secondary prevention oflipoid pneumonia.<ref name="MarchioriZanetti2011">{{cite journal|last1=Marchiori|first1=Edson|last2=Zanetti|first2=Gláucia|last3=Mano|first3=Claudia Mauro|last4=Hochhegger|first4=Bruno|title=Exogenous lipoid pneumonia. Clinical and radiological manifestations|journal=Respiratory Medicine|volume=105|issue=5|year=2011|pages=659–666|issn=09546111|doi=10.1016/j.rmed.2010.12.001}}</ref>
 
OR
 
Effective measures for the secondary prevention of [disease name] include:
*[Strategy 1]
*[Strategy 2]
*[Strategy 3]


==References==
==References==

Latest revision as of 02:52, 23 October 2019


Lipoid pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lipoid pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lipoid pneumonia secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lipoid pneumonia secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lipoid pneumonia secondary prevention

CDC on Lipoid pneumonia secondary prevention

Lipoid pneumonia secondary prevention in the news

Blogs on Lipoid pneumonia secondary prevention

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Lipoid pneumonia secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]

Overview

There are no established measures for the secondary prevention of lipoid pneumonia.

Secondary Prevention

There are no established measures for the secondary prevention oflipoid pneumonia.[1]

References

  1. Marchiori, Edson; Zanetti, Gláucia; Mano, Claudia Mauro; Hochhegger, Bruno (2011). "Exogenous lipoid pneumonia. Clinical and radiological manifestations". Respiratory Medicine. 105 (5): 659–666. doi:10.1016/j.rmed.2010.12.001. ISSN 0954-6111.

Template:WH Template:WS